The effect of Bifidobacterium on DPP-4 inhibitor in T2DM patients
Not Applicable
- Conditions
- Type 2 Diabetes
- Registration Number
- JPRN-UMIN000007899
- Lead Sponsor
- Department of Medicine, Shiga University of Medical Science
- Brief Summary
Primary outcome, HbA1c showed no significant difference compared to baseline. However, plasma GLP-1 concentration was significantly increased after Bifidobacterium treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)past history of the allergy to Bifidobacterium 2)patients who are judged to be ineligible by the investigator for some reason 3)HbA1c(NGSP)>=10%
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c and glycoalbumin concentration after Bifidobacterium treatment
- Secondary Outcome Measures
Name Time Method Bacterial flora lipid profile incidence of hypoglycemia Short chain fatty acid